Home › Funds › University of Wisconsin Foundation › DYN
University of Wisconsin Foundation position in DYN
DYNE THERAPEUTICS INC · Health Care
University of Wisconsin Foundation reported holding 313,559 shares of DYN (DYNE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 3.46% of its reported portfolio and ranking #10 among its reported holdings. University of Wisconsin Foundation has disclosed DYN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How University of Wisconsin Foundation's DYN position evolved
University of Wisconsin Foundation first disclosed a stake in DYN in Q3 2025 at 517,750 shares (US$6.5M). The position peaked in Q1 2026 at 484,745 shares, worth US$8.8M. Across 5 filings, University of Wisconsin Foundation increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 313,559 shares valued at US$5.1M. Notable position changes include a 35% trim in Q2 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 517.75K | $6.55M | New |
| Q4 2025 | 416.75K | $8.15M | Reduce |
| Q1 2026 | 484.75K | $8.79M | Add |
| Q2 2026 | 313.56K | $6.96M | Reduce |
| Q3 2026 | 313.56K | $5.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DYN and 13F data
DYN (DYNE THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in DYN — the largest reported positions include TCG Crossover Management, LLC (US$102.5M), FCPM III SERVICES B.V. (US$85.5M), Vestal Point Capital, LP (US$75.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DYN
- TCG Crossover Management, LLC 4.62M sh · $102.50M · Q2 2026
- FCPM III SERVICES B.V. 3.85M sh · $85.47M · Q2 2026
- Vestal Point Capital, LP 3.38M sh · $74.96M · Q2 2026
- ORBIMED ADVISORS LLC 3.24M sh · $71.86M · Q2 2026
- Frazier Life Sciences Management, L.P. 3.15M sh · $70.03M · Q2 2026
- ARMISTICE CAPITAL, LLC 3.09M sh · $68.57M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.69M sh · $59.73M · Q2 2026
- Logos Global Management LP 2.55M sh · $56.64M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 3.44M sh · $55.43M · Q3 2026
- Venrock Adviser, LLC 2.17M sh · $48.28M · Q2 2026
- MPM BioImpact LLC 1.92M sh · $42.69M · Q2 2026
- Siren, L.L.C. 2.43M sh · $39.13M · Q3 2026
More on University of Wisconsin Foundation
FAQ
How long has University of Wisconsin Foundation held DYN?
University of Wisconsin Foundation has disclosed DYN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is University of Wisconsin Foundation's current position in DYN?
As of Q3 2026, University of Wisconsin Foundation holds 313.56K shares of DYN (DYNE THERAPEUTICS INC), valued at $5.05M, representing 3.46% of its reported portfolio and ranking #10.
Has University of Wisconsin Foundation been buying or selling DYN?
In the latest 13F filing (Q3 2026), University of Wisconsin Foundation held unchanged its position in DYN. The position peaked in Q1 2026 at 484.75K shares.
Which other funds hold DYN?
Other major institutional holders of DYN include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Vestal Point Capital, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.